APO Research
Talk to an analyst

APO RESEARCH · REPORT

Remicade Biosimilar

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Remicade Biosimilar Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchRemicade Biosimilar Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Remicade Biosimilar Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Remicade Biosimilar Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Remicade Biosimilar Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Remicade Biosimilar Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Remicade Biosimilar market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Remicade Biosimilar include Walvax Biotechnology, Livzon Pharmaceutical, Hualan Biological Engineering, Hisun Pharmaceutical, Fosun Pharmaceutical, Anke Biotechnology, Synthon Pharmaceuticals, Novartis (Sandoz) and Merck Serono (Merck Group), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Remicade Biosimilar market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Remicade Biosimilar and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Remicade Biosimilar sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Remicade Biosimilar market size, projected growth trends, production technologies, key applications, and end-use industries.

Remicade Biosimilar Segment by Company

Walvax Biotechnology

Livzon Pharmaceutical

Hualan Biological Engineering

Hisun Pharmaceutical

Fosun Pharmaceutical

Anke Biotechnology

Synthon Pharmaceuticals

Novartis (Sandoz)

Merck Serono (Merck Group)

LG Life Sciences

Hospira

Genentech (Roche Group)

Celltrion

Biogen idec Inc.

Biocon

Remicade Biosimilar Segment by Type

100mg/10ml

500mg/50ml

Remicade Biosimilar Segment by Application

Blood Disorders

Oncology Diseases

Remicade Biosimilar Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remicade Biosimilar market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Remicade Biosimilar and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remicade Biosimilar.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Remicade Biosimilar market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Remicade Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Remicade Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Remicade Biosimilar Industry Trends Table 2. Remicade Biosimilar Industry Drivers Table 3. Remicade Biosimilar Industry Opportunities and Challenges Table 4. Remicade Biosimilar Industry Restraints Table 5. Global Remicade Biosimilar Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Remicade Biosimilar Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Remicade Biosimilar Sales by Manufacturers (L) & (2021-2026) Table 8. Global Remicade Biosimilar Sales Market Share by Manufacturers Table 9. Global Remicade Biosimilar Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global Remicade Biosimilar Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Remicade Biosimilar Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Remicade Biosimilar Manufacturers, Product Type & Application Table 13. Global Remicade Biosimilar Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Remicade Biosimilar by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg/10ml Table 17. Major Manufacturers of 500mg/50ml Table 18. Global Remicade Biosimilar Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 20. Global Remicade Biosimilar Sales by Type (2027-2032) & (L) Table 21. Global Remicade Biosimilar Sales Market Share by Type (2021-2026) Table 22. Global Remicade Biosimilar Sales Market Share by Type (2027-2032) Table 23. Global Remicade Biosimilar Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global Remicade Biosimilar Revenue by Type (2021-2026) & (L) Table 25. Global Remicade Biosimilar Revenue by Type (2027-2032) & (L) Table 26. Global Remicade Biosimilar Revenue Market Share by Type (2021-2026) Table 27. Global Remicade Biosimilar Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Blood Disorders Table 29. Major Manufacturers of Oncology Diseases Table 30. Global Remicade Biosimilar Sales by Application 2021 VS 2025 VS 2032 (L) Table 31. Global Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 32. Global Remicade Biosimilar Sales by Application (2027-2032) & (L) Table 33. Global Remicade Biosimilar Sales Market Share by Application (2021-2026) Table 34. Global Remicade Biosimilar Sales Market Share by Application (2027-2032) Table 35. Global Remicade Biosimilar Revenue by Application 2021 VS 2025 VS 2032 (L) Table 36. Global Remicade Biosimilar Revenue by Application (2021-2026) & (L) Table 37. Global Remicade Biosimilar Revenue by Application (2027-2032) & (L) Table 38. Global Remicade Biosimilar Revenue Market Share by Application (2021-2026) Table 39. Global Remicade Biosimilar Revenue Market Share by Application (2027-2032) Table 40. Global Remicade Biosimilar Sales by Region: 2021 VS 2025 VS 2032 (L) Table 41. Global Remicade Biosimilar Sales by Region (2021-2026) & (L) Table 42. Global Remicade Biosimilar Sales Market Share by Region (2021-2026) Table 43. Global Remicade Biosimilar Sales Forecasted by Region (2027-2032) & (L) Table 44. Global Remicade Biosimilar Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 46. North America Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 47. North America Remicade Biosimilar Sales by Country (2027-2032) & (L) Table 48. Europe Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 49. Europe Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 50. Europe Remicade Biosimilar Sales by Country (2027-2032) & (L) Table 51. Asia Pacific Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 52. Asia Pacific Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 53. Asia Pacific Remicade Biosimilar Sales by Country (2027-2032) & (L) Table 54. South America, Middle East and Africa Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 55. South America, Middle East and Africa Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 56. South America, Middle East and Africa Remicade Biosimilar Sales by Country (2027-2032) & (L) Table 57. Global Remicade Biosimilar Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Remicade Biosimilar Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Remicade Biosimilar Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Remicade Biosimilar Revenue Market Share by Region (2021-2026) Table 61. Global Remicade Biosimilar Revenue Market Share by Region (2027-2032) Table 62. Walvax Biotechnology Company Information Table 63. Walvax Biotechnology Business Overview Table 64. Walvax Biotechnology Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Walvax Biotechnology Remicade Biosimilar Product Portfolio Table 66. Walvax Biotechnology Recent Development Table 67. Livzon Pharmaceutical Company Information Table 68. Livzon Pharmaceutical Business Overview Table 69. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Livzon Pharmaceutical Remicade Biosimilar Product Portfolio Table 71. Livzon Pharmaceutical Recent Development Table 72. Hualan Biological Engineering Company Information Table 73. Hualan Biological Engineering Business Overview Table 74. Hualan Biological Engineering Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hualan Biological Engineering Remicade Biosimilar Product Portfolio Table 76. Hualan Biological Engineering Recent Development Table 77. Hisun Pharmaceutical Company Information Table 78. Hisun Pharmaceutical Business Overview Table 79. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hisun Pharmaceutical Remicade Biosimilar Product Portfolio Table 81. Hisun Pharmaceutical Recent Development Table 82. Fosun Pharmaceutical Company Information Table 83. Fosun Pharmaceutical Business Overview Table 84. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Fosun Pharmaceutical Remicade Biosimilar Product Portfolio Table 86. Fosun Pharmaceutical Recent Development Table 87. Anke Biotechnology Company Information Table 88. Anke Biotechnology Business Overview Table 89. Anke Biotechnology Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Anke Biotechnology Remicade Biosimilar Product Portfolio Table 91. Anke Biotechnology Recent Development Table 92. Synthon Pharmaceuticals Company Information Table 93. Synthon Pharmaceuticals Business Overview Table 94. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Synthon Pharmaceuticals Remicade Biosimilar Product Portfolio Table 96. Synthon Pharmaceuticals Recent Development Table 97. Novartis (Sandoz) Company Information Table 98. Novartis (Sandoz) Business Overview Table 99. Novartis (Sandoz) Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Novartis (Sandoz) Remicade Biosimilar Product Portfolio Table 101. Novartis (Sandoz) Recent Development Table 102. Merck Serono (Merck Group) Company Information Table 103. Merck Serono (Merck Group) Business Overview Table 104. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merck Serono (Merck Group) Remicade Biosimilar Product Portfolio Table 106. Merck Serono (Merck Group) Recent Development Table 107. LG Life Sciences Company Information Table 108. LG Life Sciences Business Overview Table 109. LG Life Sciences Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. LG Life Sciences Remicade Biosimilar Product Portfolio Table 111. LG Life Sciences Recent Development Table 112. Hospira Company Information Table 113. Hospira Business Overview Table 114. Hospira Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Hospira Remicade Biosimilar Product Portfolio Table 116. Hospira Recent Development Table 117. Genentech (Roche Group) Company Information Table 118. Genentech (Roche Group) Business Overview Table 119. Genentech (Roche Group) Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Genentech (Roche Group) Remicade Biosimilar Product Portfolio Table 121. Genentech (Roche Group) Recent Development Table 122. Celltrion Company Information Table 123. Celltrion Business Overview Table 124. Celltrion Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Celltrion Remicade Biosimilar Product Portfolio Table 126. Celltrion Recent Development Table 127. Biogen idec Inc. Company Information Table 128. Biogen idec Inc. Business Overview Table 129. Biogen idec Inc. Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Biogen idec Inc. Remicade Biosimilar Product Portfolio Table 131. Biogen idec Inc. Recent Development Table 132. Biocon Company Information Table 133. Biocon Business Overview Table 134. Biocon Remicade Biosimilar Sales (L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Biocon Remicade Biosimilar Product Portfolio Table 136. Biocon Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Remicade Biosimilar Distributors List Table 140. Remicade Biosimilar Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Remicade Biosimilar Product Image Figure 2. Global Remicade Biosimilar Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Remicade Biosimilar Market Size (2021-2032) & (US$ Million) Figure 4. Global Remicade Biosimilar Sales (2021-2032) & (L) Figure 5. Global Remicade Biosimilar Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 Remicade Biosimilar Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg/10ml Image Figure 9. 500mg/50ml Image Figure 10. Global Remicade Biosimilar Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global Remicade Biosimilar Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Remicade Biosimilar Sales Market Share by Type (2021-2032) Figure 13. Global Remicade Biosimilar Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Remicade Biosimilar Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Remicade Biosimilar Revenue Market Share by Type (2021-2032) Figure 16. Blood Disorders Image Figure 17. Oncology Diseases Image Figure 18. Global Remicade Biosimilar Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 19. Global Remicade Biosimilar Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Remicade Biosimilar Sales Market Share by Application (2021-2032) Figure 21. Global Remicade Biosimilar Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 22. Global Remicade Biosimilar Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Remicade Biosimilar Revenue Market Share by Application (2021-2032) Figure 24. North America Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 25. North America Remicade Biosimilar Sales Market Share by Country (2021-2032) Figure 26. U.S. Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 27. Canada Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 28. Mexico Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 29. Europe Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe Remicade Biosimilar Sales Market Share by Country (2021-2032) Figure 31. Germany Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 32. France Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 33. U.K. Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 34. Italy Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 35. Netherlands Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 36. Asia Pacific Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific Remicade Biosimilar Sales Market Share by Country (2021-2032) Figure 38. China Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 39. Japan Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 40. South Korea Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 41. Southeast Asia Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 42. India Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 43. Australia Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 44. South America, Middle East and Africa Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa Remicade Biosimilar Sales Market Share by Country (2021-2032) Figure 46. Brazil Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 47. South Africa Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 48. Saudi Arabia Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 49. Turkey Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 50. Argentina Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 51. UAE Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 52. Egypt Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 53. Chile Remicade Biosimilar Sales and Growth Rate (2021-2032) & (L) Figure 54. Global Remicade Biosimilar Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Remicade Biosimilar Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Remicade Biosimilar Revenue (2021-2032) & (US$ Million) Figure 57. North America Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Remicade Biosimilar Revenue (2021-2032) & (US$ Million) Figure 59. Europe Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Remicade Biosimilar Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Remicade Biosimilar Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Remicade Biosimilar Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Remicade Biosimilar Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/10ml
  • 500mg/50ml
Applications
  • Blood Disorders
  • Oncology Diseases
Companies covered
  • Walvax Biotechnology
  • Livzon Pharmaceutical
  • Hualan Biological Engineering
  • Hisun Pharmaceutical
  • Fosun Pharmaceutical
  • Anke Biotechnology
  • Synthon Pharmaceuticals
  • Novartis (Sandoz)
  • Merck Serono (Merck Group)
  • LG Life Sciences
  • Hospira
  • Genentech (Roche Group)
  • Celltrion
  • Biogen idec Inc.
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Remicade Biosimilar Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Remicade Biosimilar Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Remicade Biosimilar Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Remicade Biosimilar Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Remicade Biosimilar Market Dynamics
  1. 2.1 Remicade Biosimilar Industry Trends
  2. 2.2 Remicade Biosimilar Industry Drivers
  3. 2.3 Remicade Biosimilar Industry Opportunities and Challenges
  4. 2.4 Remicade Biosimilar Industry Restraints
3 Remicade Biosimilar Market by Manufacturers
  1. 3.1 Global Remicade Biosimilar Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Remicade Biosimilar Sales by Manufacturers (2021-2026)
  3. 3.3 Global Remicade Biosimilar Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Remicade Biosimilar Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Remicade Biosimilar Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Remicade Biosimilar Manufacturers, Product Type & Application
  7. 3.7 Global Remicade Biosimilar Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Remicade Biosimilar Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Remicade Biosimilar Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Remicade Biosimilar Tier 1, Tier 2, and Tier 3
4 Remicade Biosimilar Market by Type
  1. 4.1 Remicade Biosimilar Type Introduction
  2. 4.1.1 100mg/10ml
  3. 4.1.2 500mg/50ml
  4. 4.2 Global Remicade Biosimilar Sales by Type
  5. 4.2.1 Global Remicade Biosimilar Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Remicade Biosimilar Sales by Type (2021-2032)
  7. 4.2.3 Global Remicade Biosimilar Sales Market Share by Type (2021-2032)
  8. 4.3 Global Remicade Biosimilar Revenue by Type
  9. 4.3.1 Global Remicade Biosimilar Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Remicade Biosimilar Revenue by Type (2021-2032)
  11. 4.3.3 Global Remicade Biosimilar Revenue Market Share by Type (2021-2032)
5 Remicade Biosimilar Market by Application
  1. 5.1 Remicade Biosimilar Application Introduction
  2. 5.1.1 Blood Disorders
  3. 5.1.2 Oncology Diseases
  4. 5.2 Global Remicade Biosimilar Sales by Application
  5. 5.2.1 Global Remicade Biosimilar Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Remicade Biosimilar Sales by Application (2021-2032)
  7. 5.2.3 Global Remicade Biosimilar Sales Market Share by Application (2021-2032)
  8. 5.3 Global Remicade Biosimilar Revenue by Application
  9. 5.3.1 Global Remicade Biosimilar Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Remicade Biosimilar Revenue by Application (2021-2032)
  11. 5.3.3 Global Remicade Biosimilar Revenue Market Share by Application (2021-2032)
6 Global Remicade Biosimilar Sales by Region
  1. 6.1 Global Remicade Biosimilar Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Remicade Biosimilar Sales by Region (2021-2032)
  3. 6.2.1 Global Remicade Biosimilar Sales by Region (2021-2026)
  4. 6.2.2 Global Remicade Biosimilar Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Remicade Biosimilar Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Remicade Biosimilar Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Remicade Biosimilar Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Remicade Biosimilar Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Remicade Biosimilar Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Remicade Biosimilar Revenue by Region
  1. 7.1 Global Remicade Biosimilar Revenue by Region
  2. 7.1.1 Global Remicade Biosimilar Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Remicade Biosimilar Revenue by Region (2021-2026)
  4. 7.1.3 Global Remicade Biosimilar Revenue by Region (2027-2032)
  5. 7.1.4 Global Remicade Biosimilar Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Remicade Biosimilar Revenue (2021-2032)
  8. 7.2.2 North America Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Remicade Biosimilar Revenue (2021-2032)
  11. 7.3.2 Europe Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Remicade Biosimilar Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Remicade Biosimilar Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Remicade Biosimilar Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Walvax Biotechnology
  2. 8.1.1 Walvax Biotechnology Company Information
  3. 8.1.2 Walvax Biotechnology Business Overview
  4. 8.1.3 Walvax Biotechnology Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Walvax Biotechnology Remicade Biosimilar Product Portfolio
  6. 8.1.5 Walvax Biotechnology Recent Developments
  7. 8.2 Livzon Pharmaceutical
  8. 8.2.1 Livzon Pharmaceutical Company Information
  9. 8.2.2 Livzon Pharmaceutical Business Overview
  10. 8.2.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Livzon Pharmaceutical Remicade Biosimilar Product Portfolio
  12. 8.2.5 Livzon Pharmaceutical Recent Developments
  13. 8.3 Hualan Biological Engineering
  14. 8.3.1 Hualan Biological Engineering Company Information
  15. 8.3.2 Hualan Biological Engineering Business Overview
  16. 8.3.3 Hualan Biological Engineering Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hualan Biological Engineering Remicade Biosimilar Product Portfolio
  18. 8.3.5 Hualan Biological Engineering Recent Developments
  19. 8.4 Hisun Pharmaceutical
  20. 8.4.1 Hisun Pharmaceutical Company Information
  21. 8.4.2 Hisun Pharmaceutical Business Overview
  22. 8.4.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hisun Pharmaceutical Remicade Biosimilar Product Portfolio
  24. 8.4.5 Hisun Pharmaceutical Recent Developments
  25. 8.5 Fosun Pharmaceutical
  26. 8.5.1 Fosun Pharmaceutical Company Information
  27. 8.5.2 Fosun Pharmaceutical Business Overview
  28. 8.5.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fosun Pharmaceutical Remicade Biosimilar Product Portfolio
  30. 8.5.5 Fosun Pharmaceutical Recent Developments
  31. 8.6 Anke Biotechnology
  32. 8.6.1 Anke Biotechnology Company Information
  33. 8.6.2 Anke Biotechnology Business Overview
  34. 8.6.3 Anke Biotechnology Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Anke Biotechnology Remicade Biosimilar Product Portfolio
  36. 8.6.5 Anke Biotechnology Recent Developments
  37. 8.7 Synthon Pharmaceuticals
  38. 8.7.1 Synthon Pharmaceuticals Company Information
  39. 8.7.2 Synthon Pharmaceuticals Business Overview
  40. 8.7.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Synthon Pharmaceuticals Remicade Biosimilar Product Portfolio
  42. 8.7.5 Synthon Pharmaceuticals Recent Developments
  43. 8.8 Novartis (Sandoz)
  44. 8.8.1 Novartis (Sandoz) Company Information
  45. 8.8.2 Novartis (Sandoz) Business Overview
  46. 8.8.3 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis (Sandoz) Remicade Biosimilar Product Portfolio
  48. 8.8.5 Novartis (Sandoz) Recent Developments
  49. 8.9 Merck Serono (Merck Group)
  50. 8.9.1 Merck Serono (Merck Group) Company Information
  51. 8.9.2 Merck Serono (Merck Group) Business Overview
  52. 8.9.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Serono (Merck Group) Remicade Biosimilar Product Portfolio
  54. 8.9.5 Merck Serono (Merck Group) Recent Developments
  55. 8.10 LG Life Sciences
  56. 8.10.1 LG Life Sciences Company Information
  57. 8.10.2 LG Life Sciences Business Overview
  58. 8.10.3 LG Life Sciences Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LG Life Sciences Remicade Biosimilar Product Portfolio
  60. 8.10.5 LG Life Sciences Recent Developments
  61. 8.11 Hospira
  62. 8.11.1 Hospira Company Information
  63. 8.11.2 Hospira Business Overview
  64. 8.11.3 Hospira Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hospira Remicade Biosimilar Product Portfolio
  66. 8.11.5 Hospira Recent Developments
  67. 8.12 Genentech (Roche Group)
  68. 8.12.1 Genentech (Roche Group) Company Information
  69. 8.12.2 Genentech (Roche Group) Business Overview
  70. 8.12.3 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genentech (Roche Group) Remicade Biosimilar Product Portfolio
  72. 8.12.5 Genentech (Roche Group) Recent Developments
  73. 8.13 Celltrion
  74. 8.13.1 Celltrion Company Information
  75. 8.13.2 Celltrion Business Overview
  76. 8.13.3 Celltrion Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Celltrion Remicade Biosimilar Product Portfolio
  78. 8.13.5 Celltrion Recent Developments
  79. 8.14 Biogen idec Inc.
  80. 8.14.1 Biogen idec Inc. Company Information
  81. 8.14.2 Biogen idec Inc. Business Overview
  82. 8.14.3 Biogen idec Inc. Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biogen idec Inc. Remicade Biosimilar Product Portfolio
  84. 8.14.5 Biogen idec Inc. Recent Developments
  85. 8.15 Biocon
  86. 8.15.1 Biocon Company Information
  87. 8.15.2 Biocon Business Overview
  88. 8.15.3 Biocon Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biocon Remicade Biosimilar Product Portfolio
  90. 8.15.5 Biocon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Remicade Biosimilar Value Chain Analysis
  2. 9.1.1 Remicade Biosimilar Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Remicade Biosimilar Production Mode & Process
  6. 9.2 Remicade Biosimilar Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Remicade Biosimilar Distributors
  9. 9.2.3 Remicade Biosimilar Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst